rs376504548
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM1BP4_Moderate
The NM_000256.3(MYBPC3):c.2873C>T(p.Thr958Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000168 in 1,592,732 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000256.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYBPC3 | NM_000256.3 | c.2873C>T | p.Thr958Ile | missense_variant | 27/35 | ENST00000545968.6 | NP_000247.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.2873C>T | p.Thr958Ile | missense_variant | 27/35 | 5 | NM_000256.3 | ENSP00000442795 | P4 | |
MYBPC3 | ENST00000399249.6 | c.2873C>T | p.Thr958Ile | missense_variant | 26/34 | 5 | ENSP00000382193 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000236 AC: 36AN: 152238Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.0000982 AC: 23AN: 234236Hom.: 0 AF XY: 0.000102 AC XY: 13AN XY: 127554
GnomAD4 exome AF: 0.000161 AC: 232AN: 1440494Hom.: 1 Cov.: 31 AF XY: 0.000140 AC XY: 100AN XY: 714468
GnomAD4 genome AF: 0.000236 AC: 36AN: 152238Hom.: 1 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74378
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Feb 05, 2024 | This missense variant replaces threonine with isoleucine at codon 958 of the MYBPC3 protein. Computational prediction tools indicate that this variant has a neutral impact on protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with hypertrophic cardiomyopathy (PMID: 15823648, 18957093, 24793961, 25078086, 27532257, 33495597). This variant has been observed in one infant affected with hypertrophic cardiomyopathy, whose unaffected parent also carried this variant, as well as in one adult who also carried a pathogenic MYBPC3 variant in cis (ClinVar SCV000059185.5). This variant has been identified in 43/265618 chromosomes in the general population by the Genome Aggregation Database (gnomAD), including one homozygous individual. The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | research | Biesecker Lab/Clinical Genomics Section, National Institutes of Health | Apr 05, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2023 | This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 958 of the MYBPC3 protein (p.Thr958Ile). This variant is present in population databases (rs376504548, gnomAD 0.03%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with dilated and/or hypertrophic cardiomyopathy (PMID: 15823648, 18957093, 24793961, 25078086, 27532257, 28416588). ClinVar contains an entry for this variant (Variation ID: 42664). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 20, 2016 | Variant classified as Uncertain Significance - Favor Benign. The p.Thr958Ile var iant in MYBPC3 has been reported in 4 individuals with HCM, one of whom carried another pathogenic MYBPC3 variant (Kabaeva 2005, Ehlermann 2008, Adalsteinsdotti r 2014, Bos 2014). In addition, this variant has been identified by our laborato ry in 3 individuals with HCM, (including one infant whose unaffected parent also carried this variant, as well as one adult who also carried a pathogenic MYBPC3 variant (in cis)) and 1 individual with DCM. This variant has been identified i n 7/61564 European chromosomes by the Exome Aggregation Consortium (ExAC, http:/ /exac.broadinstitute.org/; dbSNP rs376504548). Threonine at position 958 is not conserved in evolution and 1 mammal (Bactrian camel) and multiple bird species h ave an isoleucine (Ile) at this position, suggesting that this change may be tol erated. In addition, this change was predicted to be benign using a computationa l tool clinically validated by our laboratory. This tool's benign prediction is estimated to be correct 89% of the time (Jordan 2011). In summary, while the cli nical significance of the p.Thr958Ile variant is uncertain, collectively these d ata suggest that it is more likely to be benign. - |
Uncertain significance, no assertion criteria provided | clinical testing | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Apr 09, 2013 | Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. p.Thr958Ile (c.2873 C>T) in MYBPC3 Based on the data reviewed below we consider this a variant of uncertain significance. This variant has been seen in 2 presumably unrelated cases of HCM and a case of infantile DCM. It has also been observed in general population and control samples. No segregation is available. Kabaeva et al (2005) reported this variant in a German male diagnosed with HCM at age 25. Ehlermann et al (2008) reported another German case of HCM with this variant. That patient was a male diagnosed at 46 years of age. These two cases appear to be different cases, given the reported ages of diagnosis. GeneDx reports that p.Thr958Ile was identified in an additional unrelated individual who was diagnosed with DCM in infancy and tested in their lab. I could not find any functional or experimental data on this variant or other variants at this or nearby codons reported in association with disease. In silico analysis with polyphen2 predicts this variant to be benign. The threonine at codon 958 is not conserved across species; it is an isoleucine in chickens, and glutamate in c. elegans. The variant has been seen in 3 of 5154 general population samples. Neither Ehlermann et al (2008) or Kabaeva et al (2005) reported control data. There is no variation listed at this codon in dbSNP or 1000 genomes (as of January 27, 2012). However, the variant was observed in 2 of 3346 Caucasian individuals and 0 of 1608 African Americans in the NHLBI Exome Sequencing Project dataset (as of January 27, 2012). The phenotype of those two individuals is not available, however given the way the samples were accrued, we consider this a general population sample unselected for Mendelian cardiac disease. - |
Cardiomyopathy Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Dec 07, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Dec 21, 2023 | This missense variant replaces threonine with isoleucine at codon 958 of the MYBPC3 protein. Computational prediction tools indicate that this variant has a neutral impact on protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with hypertrophic cardiomyopathy (PMID: 15823648, 18957093, 24793961, 25078086, 27532257, 33495597). This variant has been observed in one infant affected with hypertrophic cardiomyopathy, whose unaffected parent also carried this variant, as well as in one adult who also carried a pathogenic MYBPC3 variant in cis (ClinVar SCV000059185.5). This variant has been identified in 43/265618 chromosomes in the general population by the Genome Aggregation Database (gnomAD), including one homozygous individual. The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2022 | MYBPC3: BP4 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 07, 2019 | This variant is associated with the following publications: (PMID: 25078086, 21415409, 15823648, 18957093, 29247119, 23861362, 23299917, 25637381, 22958901, 27532257, 24793961, 28416588, 28518168) - |
Primary familial hypertrophic cardiomyopathy Uncertain:1
Uncertain significance, no assertion criteria provided | research | CSER _CC_NCGL, University of Washington | Jun 01, 2014 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 09, 2022 | The c.2873C>T (p.T958I) alteration is located in exon 27 (coding exon 27) of the MYBPC3 gene. This alteration results from a C to T substitution at nucleotide position 2873, causing the threonine (T) at amino acid position 958 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
MYBPC3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 13, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at